CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Spectra Optia Apheresis Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02308787
NCT02308787N/ACompleted
CompareCT.gov

Multicenter, Retrospective Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for Platelet Depletion Procedures.

Terumo BCT·observational·Posted Dec 4, 2014·Updated Jun 15, 2016

In Brief

An observational study evaluating Spectra Optia Apheresis System for Thrombocythemia and 2 related conditions. Completed, enrolled 12 participants across 2 sites in 2 countries.

Detailed Summary

Multicenter, Retrospective Data Collection of Routine Clinical Use with the Spectra Optia® Apheresis System for Platelet Depletion Procedures.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsThrombocythemia, Myeloproliferative Disease, Thrombocytosis
CountriesDenmark, Hungary
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 4, 2014
Enrollment StartNov 1, 2014
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.6 years ago

Interventions

Spectra Optia Apheresis Systemdevice

Platelet Depletion